Opinion on Pharmaceuticals and Healthcare in Germany

Published within

« | ... | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ... | » »|

Type Product title / description Pub Price
ResearchWire
ResearchWire

Neuropathic back pain: 5.4 million US sufferers

Published By Datamonitor
15 Apr 2002
ResearchWire
ResearchWire

Acute heart failure: 945,000 US cases in 2001

Published By Datamonitor
17 Apr 2002
ResearchWire
ResearchWire

Endometriosis: 80% of US sufferes go undiagnosed

Published By Datamonitor
24 Apr 2002
CommentWire
CommentWire

Aventis: strong sales, despite Lovenox slowdown

Aventis's lead thrombosis drug Lovenox saw sales growth of 16.3% in Q1 2002, below its 2001 sales growth of 37.6%. This came due to lower pricing together with rivalry from competing LMWHs. Aventis will need to continue seeking new indications for Lovenox, to maintain its success among cheaper alternatives and more effective newcomers.

Published By Datamonitor
01 May 2002
ResearchWire
ResearchWire

Pain: 62,000 US CPRS sufferers in 2001

Published By Datamonitor
02 May 2002
ResearchWire
ResearchWire

eHealth: US physicians online 5.4 hours per week

Published By Datamonitor
09 May 2002
ResearchWire
ResearchWire

Coronary surgery: UK procedures to increase 1%

Published By Datamonitor
10 May 2002
ResearchWire
ResearchWire

Herpes simplex virus: Germany has 24.6 million cases

Published By Datamonitor
28 May 2002
ResearchWire
ResearchWire

Lung cancer: 189,900 new sufferers in the US

Published By Datamonitor
05 Jun 2002
ResearchWire
ResearchWire

Heart failure: 5.6 million chronic US cases in 2001

Published By Datamonitor
11 Jun 2002

« | ... | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ... | » »|

No help is available.